Abstract
Rats treated chronically with Δ 9-tetrahydrocannabinol (THC, daily oral dose 20 mg/kg) were examined for residual effects on a variety of behaviors following a 1–4 month drug-free period. Learning a 12-arm radial maze and a differential reinforcement of low-rate responding (DRL-20) task was significantly retarded in THC-treated animals, although performance reached control levels by the end of testing. Learning two-way shuttle box avoidance was slightly facilitated in the drug-treated subjects. In open field tests THC-treated rats displayed an initial hypoactivity, followed by hyperactivity, but these changes were not significant. Most of the effects of THC resemble, but are weaker than those of chronic treatment with cannabis extract in a dose containing the same amount of THC. The findings are discussed in terms of the role of other constituents of cannabis that may add to, or potentiate the effects of THC itself.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anderson PF, Jackson DM, Chesher GB (1974) Interaction of Δ 9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice. J Pharm Pharmacol 26:136–137
Bird KD, Boleyn T, Chesher GB, Jackson DM, Starmer GA, Teo RKC (1980) Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance. Psychopharmacology 71:181–188
Brady KT, Balster RL (1980) The effects of Δ 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in Rhesus monkeys. Psychopharmacology 72:21–26
Carlini EA, Karniol IG, Renault PF, Schuster CR (1974) Effects of marihuana in laboratory animals and man. Br J Pharmacol 50:299–309
Fairbairn JW, Pickens JT (1981) Activity of cannabis in relation to its Δ 1-trans-tetrahydrocannabinol content. Br J Pharamacol 72:401–409
Fehr KO (1977) The behavioral toxicity of cannabis in the rat. PhD thesis, University of Toronto, Toronto, Canada
Fehr KO, Kalant H, LeBlanc AE (1976) Residual learning deficit after heavy exposure to cannabis or alcohol in rats. Science 193:1249–1251
Fernandes M, Schabarek A, Coper H, Hill R (1974) Modification of Δ 9-THC actions by cannabinol and cannabidiol in the rat. Psychopharmacologia 38:329–338
Fernandes M, Worning N, Christ W, Hill R (1973) Interactions of several cannabinoids with the hepatic drug metabolizing system. Biochem Pharmacol 22:2981–2987
Galanter M, Weingartner H, Vaughen TB, Roth WT, Wyatt RJ (1973) Δ 9-trans-Tetrahydrocannabinol and natural marihuana. Arch Gen Psychiatry 28:278–281
Hollister LE (1974) Structure-activity relationships in man of cannabis constituents and homologs and metabolites of Δ 9-tetrahydrocannabinol. Pharmacology 11:3–11
Jones G, Pertwee RG (1972) A metabolic interaction in vivo between cannabidiol and Δ 9-tetrahydrocannabinol. Br J Pharmacol 45:375–377
Karniol IG, Carlini EA (1972) The content of (−)Δ 9-trans-tetrahydrocannabinol (Δ 9-THC) does not explain all biological activity of some Brazilian marihuana samples. J Pharm Pharmacol 24:833–835
Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE (1975) Effects of (−)Δ 9-trans-Tetrahydrocannabinol and cannabinol in man. Pharmacology 13:502–512
Kimble DP (1978) Effects of combined entorhinal cortex-hippocampal lesions on locomotor behavior, spontaneous alternation and spatial maze learning in the rat. Physiol Behav 21:177–187
Klausner HA, Dingell JV (1971) Metabolism and excretion of Δ 9-tetrahydrocannabinol in the rat. Life Sci 10:49–59
Kubena RK, Barry III H (1972) Stimulus characteristics of marihuana components. Nature 235:397–398
Mechoulam R (1970) Marihuana chemistry. Science 168:1159–1160
Mechoulam R, McCallum NK, Burstein SH (1976) Recent advances in the chemistry and biochemistry of cannabis. Chem Rev 76:75–112
Musty RE, Karniol IG, Shirakawa I, Takahashi RN, Knobel E (1976) Interactions of Δ 9-tetrahydrocannabinol and cannabinol in man. In: Braude MC, Szara S (eds) Pharmacology of marihuana, vol 2. Raven, New York, pp 559–563
Pickens JT (1981) Sedative activity of cannabis in relation to its Δ 1-trans-tetrahydrocannabinol and cannabidiol content. Br J Pharmacol 72:649–656
Rosenkrantz H (1983) Cannabis, marihuana and cannabinoid toxicological manifestations in man and animals. In: Fehr KO, Kalant H (eds) Adverse health and behavioral consequences of cannabis use. Working papers for the 1981 ARF/WHO Scientific Meeting, Addiction Research Foundation, Toronto, Canada (in press)
Steward O, Leosche J, Horton WC (1977) Behavioral correlates of denervation and reinnervation of the hippocampal formation of the rat: Open field activity and cue utilization following bilateral entorhinal cortex lesions. Brain Res Bull 2:41–48
Stiglick A, Kalant H (1982a) Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats. Psychopharmacology 77:117–123
Stiglick A, Kalant H (1982b) Residual effects of prolonged cannabis administration on exploration and DRL performance in rats. Psychopharmacology 77:124–128
Takahashi RN, Karniol IG (1975) Pharmacological interactions between cannabinol and Δ 9-tetrahydrocannabinol. Psychopharmacologia 41:277–284
Winer BJ (1971) Statistical principles in experimental design. McGraw Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stiglick, A., Kalant, H. Behavioral effects of prolonged administration of Δ 9-Tetrahydrocannabinol in the rat. Psychopharmacology 80, 325–330 (1983). https://doi.org/10.1007/BF00432114
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432114